Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

source https://www.nytimes.com/2023/05/03/health/alzheimers-drug-eli-lilly-trial.html